Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Rho-related GTP-binding protein RhoF (RHOF) (Middle Region) Peptide

RHOF Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN982966

Quick Overview for Rho-related GTP-binding protein RhoF (RHOF) (Middle Region) Peptide (ABIN982966)

Target

RhoF (RHOF) (Rho-related GTP-binding protein RhoF (RHOF))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-RHOF antibody (Catalog #: ARP57310_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    RhoF (RHOF) (Rho-related GTP-binding protein RhoF (RHOF))

    Background

    RHOF is a plasma membrane-associated small GTPase which cycles between an active GTP-bound and an inactive GDP-bound state. RHOF causes the formation of thin, actin-rich surface projections called filopodia. RHOF functions cooperatively with CDC42 and Rac

    Alias Symbols: ARHF, FLJ20247, RIF

    Protein Size: 211

    Molecular Weight

    23 kDa

    Gene ID

    54509

    NCBI Accession

    NM_019034, NP_061907

    UniProt

    Q9HBH0
You are here:
Chat with us!